L-arginine/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Increases total antioxidant capacity
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“After 30 and 60 days, significant increases in NO and TAS levels (p<0.001), as well as extended PFWD (p<0.001), were observed across all subgroups receiving L-arginine compared with controls.”
Quoted verbatim from Assessment of the effectiveness and safety of two-month oral supplementation with L-arginine depending on the type of lipid metabolism disorder in patients with atherosclerotic lower limb ischemia.. - Study
- RCT
- Dose
- 6 g/day, oral, for 30 and 60 days
- Population
- Patients over 50 years of age with Fontaine stage II atherosclerotic lower limb ischemia (hypertriglyceridemia, hypercholesterolemia and mixed hyperlipidemia subgroups)
Assessment of the effectiveness and safety of two-month oral supplementation with L-arginine depending on the type of lipid metabolism disorder in patients with atherosclerotic lower limb ischemia.2025PMID:41364169Permalink
Keep reading
- Everything the graph holds on L-arginine
- Every compound studied against Total antioxidant capacity
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M2BMMR5CQVN6AR8F94RW9H4T